International consensus statement on the peri-operative management of anaemia and iron deficiency

Anaesthesia

Volumn 72, Issue 2, 2017, Pages 233-247

  Munoz M ^a   Acheson, A G ^b   Auerbach, M ^c   Besser, M ^d   Habler, O ^e   Kehlet, H ^f   Liumbruno, G M ^g   Lasocki, S ^h   Meybohm, P ⁱ   Rao Baikady, R ^j   Richards, T ^k   Shander, A ^l   So Osman, C ^m   Spahn, D R ⁿ   Klein, A A ^o  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^e KRANKENHAUS NORDWEST   (Germany)

^f Rigshospitalet   (Denmark)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h UNIVERSITÉ D'ANGERS   (France)

ⁱ UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^j INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^k UNIVERSITY COLLEGE LONDON   (United Kingdom)

^l ENGLEWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^m GROENE HART HOSPITAL   (Netherlands)

ⁿ UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^o PAPWORTH HOSPITAL   (United Kingdom)

more..

Author keywords

anaemia; iron; pre operative assessment; transfusion

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; FERROUS SULFATE; IRON; IRON SACCHARATE; TRANSFERRIN;

ANEMIA; ARTICLE; CLINICAL PRACTICE; CONSENSUS; DRUG COST; DRUG SAFETY; FERRITIN BLOOD LEVEL; HOSPITAL ADMINISTRATOR; HUMAN; INTRAOPERATIVE PERIOD; IRON DEFICIENCY; IRON THERAPY; META ANALYSIS (TOPIC); OPERATIVE BLOOD LOSS; PATIENT CARE; PATIENT IDENTIFICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; SURGICAL PATIENT; THERAPY DELAY; TRANSFERRIN BLOOD LEVEL; DEFICIENCY; HEALTH CARE COST; INTRAVENOUS DRUG ADMINISTRATION; PERIOPERATIVE PERIOD;

ANEMIA; CONSENSUS; HEALTH CARE COSTS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; PERIOPERATIVE CARE;

EID: 85009159693     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.13773     Document Type: Article

References (93)

1. Beris P, Muñoz M, García-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management: consensus statement on the role of intravenous iron. British Journal of Anaesthesia 2008; 100: 599–604.
2. Goodnough LT, Maniatis A, Earnshaw P, et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. British Journal of Anaesthesia 2011; 106: 13–22.
3. National Blood Authority. Patient Blood Management Guidelines: Module 2 – Peri-operative. https://www.blood.gov.au/pbm-module-2 (accessed 17/08/2016).
4. Leal-Noval SR, Muñoz M, Asuero M, et al. Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the “Seville Document”. Blood Transfusion 2013; 11: 585–610.
5. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. European Journal of Anaesthesiology 2013; 30: 270–382.
6. Goodnough LT, Shander A, Spivak JL, et al. Detection, evaluation, and management of anemia in the elective surgical patient. Anesthesia and Analgesia 2005; 101: 1858–6.
7. SABM. Anemia prevention and management program implementation guide, 2015. https://www.sabm.org/sites/default/files/anemia_prevention_management_program_implementation_guide.pdf (accessed 01/08/2016).
8. Kotzé A, Harris A, Baker C, et al. British Committee for Standards in Haematology guidelines on the identification and management of pre-operative anaemia. British Journal of Haematology 2015; 171: 322–31.
9. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 2015; 122: 241–75.
10. Vaglio S, Prisco D, Biancofiore G, et al. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. Blood Transfusion 2016; 14: 23–65.
11. Klein AA, Arnold P, Bingham RM, et al. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia 2016; 71: 829–42.
12. WHO. Iron Deficiency Anaemia: Assessment, Prevention, and Control. A Guide for Programme Managers. Geneva: WHO, 2001.
13. Pasricha SR, Drakesmith H, Black J, Hipgrave D, Biggs BA. Control of iron deficiency anemia in low- and middle-income countries. Blood 2013; 121: 2607–17.
14. Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. American Journal of Clinical Nutrition 2015; 102: 1585–94.
15. Camaschella C. Iron-deficiency anemia. New England Journal of Medicine 2015; 372: 1832–43.
16. Wong CC, Ng AC, Kritharides L, Sindone AP. Iron deficiency in heart failure: looking beyond anaemia. Heart Lung Circulation 2016; 25: 209–16.
17. Patteril MV, Davey-Quinn AP, Gedney JA, Murdoch SD, Bellamy MC. Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesthesia and Intensive Care 2001; 29: 473–8.
18. Enjuanes C, Bruguera J, Grau M, et al. Iron status in chronic heart failure: impact on symptoms, functional class and submaximal exercise capacity. Revista Española de Cardiología (Engl Ed) 2016; 69: 247–55.
19. Cleland JG, Zhang J, Pellicori P, et al. Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure. JAMA Cardiology 2016; 1: 539–47.
20. Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. New England Journal of Medicine 2009; 361: 2436–48.
21. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. CONFIRM-HF Investigators. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European Heart Journal 2015; 36: 657–68.
22. García-Erce JA, Laso-Morales MJ, Gómez-Ramírez S, Núñez-Matas MJ, Muñoz M. Analysis of the prevalence and causes of low preoperative haemoglobin levels in a large multicentre cohort of patients undergoing major non-cardiac surgery. Transfusion Medicine 2016; 26(Suppl. 1): 48.
23. Harju E. Empty iron stores as a significant risk factor in abdominal surgery. Journal of Parenteral and Enteral Nutrition 1988; 12: 282–5.
24. Izuel-Ramí M, García-Erce JA, Gómez-Barrera M, et al. Relación entre la transfusión de sangre alogénica, la deficiencia de hierro y la infección nosocomial en pacientes con fractura de cadera. Medicina Clínica (Barcelona) 2008; 131: 647–52.
25. Muñoz M, García-Erce JA, Remacha AF. Disorders of iron metabolism. Part II: iron deficiency and iron overload. Journal of Clinical Pathology 2011; 64: 287–96.
26. Walters GO, Miller FM, Worwood M. Serum ferritin concentration and iron stores in normal subjects. Journal of Clinical Pathology 1973; 26: 770–2.
27. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clinical Chemistry 1998; 44: 45–51.
28. Basora M, Colomina MJ, Tio M, Mora L, Salazar F, Ciercoles E. Optimizing preoperative haemoglobin with intravenous iron. British Journal of Anaesthesia 2013; 110: 488–90.
29. Thomas DW, Hinchliffe RF, Briggs C, Macdougall IC, Littlewood T. Cavill I; British Committee for Standards in Haematology. Guideline for the laboratory diagnosis of functional iron deficiency. British Journal of Haematology 2013; 161: 639–48.
30. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S. Pre-operative haematological assessment in patients scheduled for major surgery. Anaesthesia 2016; 71(Suppl. 1): s19–28.
31. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. WHO/NMH/NHD/MNM/11.1. http://www.who.int/vmnis/indicators/haemoglobin.pdf (accessed 28/04/2016).
32. Gombotz H, Rehak PH, Shander A, Hofmann A. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007; 47: 1468–80.
33. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459–69.
34. Klein AA, Collier TJ, Brar MS, et al. The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK – the first Association of Cardiothoracic Anaesthetists national audit. Anaesthesia 2016; 71: 627–35.
35. Muñoz M, Gomez-Ramirez S, Kozek-Langeneker S, et al. ‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients. British Journal of Anaesthesia 2015; 115: 15–24.
36. Keeler B, Simpson J, Ng S, et al. The feasibility and clinical efficacy of intravenous iron administration for preoperative anaemia in patients with colorectal cancer. Colorectal Diseases 2014; 16: 794–800.
37. Hogan M, Klein AA, Richards T. The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery. European Journal of Cardiothoracic Surgery 2015; 4: 218–26.
38. Okuyama M, Ikeda K, Shibata T, Tsukahara Y, Kitada M, Shimano T. Preoperative iron supplementation and intraoperative transfusion during colorectal cancer surgery. Surgery Today 2005; 35: 36–40.
39. Bisbe E, García-Erce JA, Díez-Lobo AI, Muñoz M; Anaemia Working Group España. A multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgery. British Journal of Anaesthesia 2011; 107: 477–8.
40. Laso-Morales MJ, Gómez-Ramírez S, Pontes-García C, Díaz-espallardo C, Muñoz M. Intravenous versus oral iron for treating iron deficiency anaemia in colorectal cancer patients: a single-centre, observational cohort study. Transfusion Medicine 2016; 26(Suppl. 1): 53.
41. Froessler B, Palm P, Weber I, Hodyl NA, Singh R, Murphy EM. The important role for intravenous iron in perioperative patient blood management in major abdominal surgery: a randomized controlled trial. Annals of Surgery 2016; 264: 41–6.
42. Calleja JL, Delgado S, del Val A, et al. Colon Cancer Study Group. Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia. International Journal of Colorectal Diseases 2016; 31: 543–51.
43. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery - systematic review and meta-analysis. Annals of Surgery 2012; 256: 235–44.
44. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055–60.
45. Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB. Surgical outcomes and transfusion of minimal amounts of blood in the operating room. Archives of Surgery 2012; 147: 49–55.
46. Bisbe E, Castillo J, Sáez M, et al. Prevalence of preoperative anemia and hematinic deficiencies in patients scheduled for major orthopedic surgery. Transfusion Alternatives in Transfusion Medicine 2008; 4: 166–73.
47. Rogers BA, Cowie A, Alcock C, Rosson JW. Identification and treatment of anaemia in patients awaiting hip replacement. Annals of the Royal College of Surgeons of England 2008; 90: 504–7.
48. Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 2015; 126: 1981–9.
49. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. American Journal of Medicine 2005; 118: 1142–7.
50. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823–33.
51. Theussinger OM, Leyvraz PF, Schanz U, et al. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology 2007; 107: 923–27.
52. Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 2011; 115: 929–37.
53. Muñoz M, Gómez-Ramirez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2014; 54: 289–99.
54. García-Erce JA, Cuenca J, Martínez F, Cardona R, Pérez-Serrano L, Muñoz M. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. Transfusion Medicine 2006; 16: 335–41.
55. ®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sanguinis 2015; 109: 257–66.
56. Richards T, Clevenger B, Keidan J, et al. PREVENTT: preoperative intravenous iron to treat anaemia in major surgery: study protocol for a randomised controlled trial. Trials 2015; 16: 254.
57. Pratt JJ, Khan KS. Non-anaemic iron deficiency – a disease looking for recognition of diagnosis: a systematic review. European Journal of Haematology 2016; 96: 618–28.
58. Cuenca J, Garcia-Erce JA, Martinez F, Cardona R, Perez-Serrano L, Munoz M. Preoperative haematinics and transfusion protocol reduce the need for transfusion after total knee replacement. International Journal of Surgery 2007; 5: 89–94.
59. Lachance K, Savoie M, Bernard M, et al. Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Annals of Pharmacotherapy 2011; 45: 764–70.
60. Kotze A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. British Journal of Anaesthesia 2012; 108: 943–52.
61. Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574–81.
62. Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in noncardiac surgery: a retrospective cohort study. Lancet 2011; 378: 1396–407.
63. Leichtle SW, Mouawad NJ, Lampman R, Singal B, Cleary RK. Does preoperative anemia adversely affect colon and rectal surgery outcomes? Journal of the American College of Surgeons 2011; 212: 187–94.
64. Ranucci M, Di Dedda U, Castelvecchio S, et al. Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis. Annals of Thoracic Surgery 2012; 94: 1134–41.
65. Jans Ø, Jørgensen C, Kehlet H, Johansson PI; Lundbeck Foundation Centre for Fast-track Hip and Knee Replacement Collaborative Group. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty. Transfusion 2014; 54: 717–26.
66. Fowler AJ, Ahmad T, Phull MK, et al. Meta-analysis of the association between preoperative anaemia and mortality after surgery. British Journal of Surgery 2015; 102: 1314–24.
67. Elhenawy AM, Meyer SR, Bagshaw SM, MacArthur RG, Carroll LJ. Role of preoperative intravenous iron therapy to correct anemia before major surgery: study protocol for systematic review and meta-analysis. Systematic Reviews 2015; 4: 29.
68. Shander A, Knight K, Thurer R, Adamson J, Spence R. Prevalence and outcomes of anaemia in surgery: a systematic review of the literature. American Journal of Medicine 2004; 116(Suppl. 7A): 58–69.
69. National Institute for Clinical Excellence guidance. Blood Transfusion. https://www.nice.org.uk/guidance/ng24/resources/blood-transfusion-1837331897029 (accessed 01/08/2016).
70. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Annals of Internal Medicine 2012; 157: 49–58.
71. Muñoz M, Naviera E, Seara J, Cordero J. Effects of postoperative intravenous iron on transfusion requirements after lower limb arthroplasty. British Journal of Anaesthesia 2012; 108: 532–4.
72. Yoon HM, Kim Y-W, Nam BH, et al. Intravenous iron supplementation may be superior to observation in acute isovolemic anemia after gastrecctomy for cancer. World Journal of Gastroenterology 2014; 20: 1852–57.
73. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology 2008; 199: e1–435.
74. Bisbe E, Molto L, Arroyo R, Muniesa JM, Tejero M. Randomised trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. British Journal of Anaesthesia 2014; 113: 402–9.
75. Khalafallah AA, Yan C, Al-Badri R, et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. Lancet Haematology 2016; 3: e415–25.
76. Hod EA, Brittenham GM, Billote GB, et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood 2011; 118: 6675–82.
77. Finch CA, Miller LR, Inamdar AR, Person R, Seiler K, Mackler B. Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. Journal of Clinical Investigation 1976; 58: 447–53.
78. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J. Update on adverse drug events associated with parenteral iron. Nephrology Dialysis and Transplantation Journal 2006; 21: 378–82.
79. Serious Hazards of Transfusion Report, 2015. http://www.shotuk.org/report-summary-supplement-2015/(accessed 01/08/2016).
80. European Medicines Agency. New recommendations to manage risk of allergic reactions with intravenous iron-containing medicines. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/06/newsdetail_001833.jsp%26mid=WC0b01ac058004d5c1 (accessed 01/08/2016).
81. Rampton D, Folkersen J, Fishbane S, et al. Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica 2014; 99: 1671–6.
82. Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. American Journal of Hematology 2016; 91: 31–8.
83. Avni T, Bieber A, Grossman A, Green H, Leibovici L, Gafter-Gvili A. The safety of intravenous iron preparations: systematic review and meta-analysis. Mayo Clinic Proceedings 2015; 90: 12–23.
84. Torres S, Kuo YH, Morris K, Neibart R, Holtz JB, Davis JM. Intravenous iron following cardiac surgery does not increase the infection rate. Surgical Infections (Larchmt) 2006; 7: 361–6.
85. Andrews SC, Robinson AK, Rodríguez-Quiñones F. Bacterial iron homeostasis. FEMS Microbioly Reviews 2003; 27: 215–37.
86. Bhandari S. Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice. Therapeutics and Clinical Risk Management 2011; 7: 501–9.
87. Calvet X, Gené E, Ruiz MA, et al. Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose or oral iron as preoperative treatment in patients with colon cancer and iron deficiency anaemia. Technology and Health Care 2016; 24: 111–20.
88. Muñoz M, Gómez-Ramírez S, Martín-Montañez E, Naveira E, Seara J, Pavía J. Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. Blood Transfusion 2014; 12: 40–9.
89. Reinisch W, Staun M, Bhandari S, Muñoz M. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. Journal of Crohn's and Colitis 2013; 7: 429–40.
90. Clevenger B, Richards T. Pre-operative anaemia. Anaesthesia 2015; 70(Suppl. 1): 20–8, e6–8.
91. Clevenger B, Mallett SV, Klein AA, Richards T. Patient blood management to reduce surgical risk. British Journal of Surgery 2015; 102: 1325–37.
92. Meybohm P, Richards T, Isbister J, et al. Patient blood management bundles to facilitate implementation. Transfusion Medicine Reviews 2017; 31: 62–71.
93. Kehlet H, Jorgensen CC. Advancing surgical outcomes research and quality improvement within an enhanced recovery program framework. Annals of Surgery 2016; 264: 237–8.